Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiuxin pill for stable angina in coronary heart disease
ChiCTR2200060780Phase 4Recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Aug 2022
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Suxiao Jiuxin Pills in stable angina and coronary arteriosclerosis (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Treadmill exercise test: total exercise time and Seattle Angina Questionnaire score. Started Aug 2022; status: recruiting.
02
Drugs
Suxiao Jiuxin Pills
03
Conditions
stable anginacoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2200060780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060780.